Funding Opportunities
Please visit the Funding Opportunities section of this website often to view specific research and training opportunities.
Antibody Production
99 – Monoclonal Antibody Generation
Solicitation Number: S08-060
Receipt Date: January 7, 2008
This solicitation is now closed and applications are no longer being accepted.
One of the top priorities identified by the cancer proteomics community is developing a series of renewable and highly characterized affinity binding reagents that are readily available to the research community. To that end, CPTC has now posted a Request for Proposals (Solicitation Number S08-060), which is aimed at soliciting applications from skilled parties to develop monoclonal antibodies against 42 cancer-related antigens already produced under the CPTC initiative.
Once a set of antibodies are generated and screened by the contractor for each antigen, the antibodies will be sent to SAIC-Frederick, the Operations and Maintenance Contractor for the NCI Frederick Cancer Research Facility, and undergo further screening and characterization. The data from all phases of the characterization, i.e. from contractor and other entities selected by NCI, will be made public through the associated web portal.
SBIR Grants
2008 Contracts
PHS 2008-1, Solicitation for SBIR Contract Proposals
253 Advances in Protein Expression of Post-Translationally Modified Cancer Related Proteins
Receipt Date: November 5, 2007
This solicitation is now closed and applications are no longer being accepted.
254 Development of Clinical Quantitative Multiplex High-Throughput Mass Spectrometric Immunoassay for Detecting Low Abundance Cancer Related Proteins/Peptides in Bodily Fluids
Receipt Date: November 5, 2007
This solicitation is now closed and applications are no longer being accepted.
Underrepresented Minority Training Grants
The NCI’s Diversity Training Branch has several grant supplements that are available to help develop specialized personnel that are members of underserved communities. These supplements are not limited by educational status: They are offered to trainees at various levels in their professional careers and awards are available for high school students through junior investigators. In applying for each grant, indicate that it is for Clinical Proteomic Technology in support of NCI's Clinical Proteomic Technologies for Cancer Initiative.
Research Supplements to Promote Diversity in Health-Related Research
PA Number: PA-05-015
Receipt Date: Applications can be received at any time
Expiration Date: September 30, 2008
Supplements to Promote Reentry into Biomedical and Behavioral Research Careers
PA Number: PA-04-126
Receipt Date: Applications can be received at any time
Expiration Date: September 8, 2008
NCI Transition Career Development Award to Promote Diversity (K22)
PA Number: PAR-05-011
Receipt Dates: Standard Dates
Expiration Date: January 3, 2008
NCI Mentored Career Development Award To Promote Diversity (K01)
PA Number: PAR-06-220
Receipt Dates: Standard Dates
Expiration Date: March 2, 2009
NCI Mentored Clinical Scientist Award to Promote Diversity (K08)
PA Number: PAR-06-221
Receipt Dates: Standard Dates
Expiration Date: March 2, 2009
Mentored Patient-Oriented Research Award to Promote Diversity (K23)
PA Number: PAR-06-222
Receipt Dates: Standard Dates
Expiration Date: March 2, 2009
Feasibility Studies for Collaborative Interaction for Minority Institution/Cancer Center Partnership (P20)
PA Number: PAR-07-230
Receipt Date: April 13, 2007; April 15, 2008; April 15, 2009
Expiration Date: April 16, 2009
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships (F31) to Promote Diversity in Health-Related Research
PA Number: PA-07-106
Receipt Dates: April 13; August 13; December 13
Expiration Date: April 14, 2010
Proteomic Reagents and Resource Core
The Proteomic Reagents and Resource Core will organize tools, reagents, and enabling technologies to support protein/peptide measurement and analysis efforts. These highly purified and characterized reagents would be used to develop improved approaches to sample preparation, fractionation, separation, detection, and quantification, as well as equipment standardization and calibration. The Core will serve as a central (virtual) source for reagents for the scientific community and will include human and mouse tissue samples, and plasma, antibodies and affinity capture reagents, labeling reagents, protein and/or peptide mixtures, and other reagents needed for effective proteomic analysis platforms. The Core does not intend to provide materials that are commercially available unless it is suspected that significant variation occurs between commercial lots (e.g., polyclonal antibodies).
To learn more about the National Institutes of Health grant programs, please visit the NIH Forms and Grant Applications website.
